- What a Salary Guide for NO Can and Cannot Tell You
- Who Actually Holds This Credential
- What Really Drives Neuro-Oncologist Pay
- Where Neuro-Oncology Physicians Work
- The Cost Side of the Equation
- Route Choice and Timeline: Why the 2027 Sitting Matters for Earnings Planning
- Keeping the Credential: C-cert as an Ongoing Expense
- Clinical Breadth the Exam Rewards
- A Domain-Weighted Prep Sequence
- Frequently Asked Questions
- NO is the UCNS physician subspecialty credential in neuro-oncology; no verified salary premium attributable to it alone exists.
- The initial exam runs in odd-numbered years, so there is no 2026 sitting; the next is December 6-10, 2027.
- UCNS lists $1,700 total, but the exact NO store page shows $2,200; verify your application invoice.
- Four alternative eligibility routes exist; you complete one, not all four.
What a Salary Guide for NO Can and Cannot Tell You
Most "salary guides" for certifications quote a single dollar figure and imply the credential created it. That approach does not hold up for Neuro-Oncology Certification (NO), and this guide will not pretend otherwise. NO, as administered by the United Council for Neurologic Subspecialties (UCNS), is a physician subspecialty credential. The people who earn it are already board-certified physicians in neurology, neurosurgery, medical oncology, radiation oncology, or related fields. Their compensation is shaped by their primary specialty, employer, region, call burden, procedural volume, and academic rank long before a neuro-oncology credential enters the picture.
No official UCNS source reports compensation data for NO holders, and no verified measurement isolates a pay premium attributable to the credential itself. So rather than invent figures, this article lays out the structural factors that determine earnings for physicians who practice neuro-oncology, the cost side of holding the credential, and how to think about return on investment honestly. If you are weighing whether to sit for the exam, pair this analysis with our complete ROI analysis of NO certification.
Who Actually Holds This Credential
Understanding earnings starts with understanding the candidate pool. Eligibility requires a qualifying primary certification, which includes ABMS certification in:
- Neurology or child neurology
- Neurological surgery
- Internal medicine and medical oncology
- Pediatrics and pediatric hematology-oncology
- Radiation oncology
Equivalent AOA or RCPSC certification also qualifies, along with current unrestricted licensure in the United States, its territories, or Canada, and in each jurisdiction of practice. In other words, NO is layered on top of an existing board certification. A neurologist who adds NO and a radiation oncologist who adds NO may have very different compensation structures for reasons that have nothing to do with the UCNS credential.
This is the first reason a single "NO salary" number would be misleading. The credential attaches to physicians drawn from at least five distinct primary specialties, each with its own pay landscape. For background on what the credential represents, see What Is NO Certification?
What Really Drives Neuro-Oncologist Pay
Because no verified premium is attributable to NO alone, the more useful question is what drives compensation for physicians whose practice centers on brain and spinal tumors and the neurologic complications of cancer. Qualitatively, these factors matter most:
Primary specialty and clinical mix
A neurosurgeon performing tumor resections, a radiation oncologist treating CNS malignancies, and a neurologist managing cancer-related neurologic disorders are compensated through different models. Procedural and treatment-delivery specialties typically follow different structures than cognitive-based consultative practice. The credential does not change which of these you are.
Practice setting
Academic medical centers, comprehensive cancer centers, community oncology groups, and hospital-employed neurology or oncology departments each use different compensation formulas. Academic roles often blend clinical, research, and teaching effort with salary tied to rank. Private and hospital-employed roles more often tie pay to productivity.
Geography and market demand
Neuro-oncology expertise concentrates in large tertiary referral centers. Physicians in regions with few subspecialists may command different terms than those in saturated metropolitan markets. These effects are real but vary too much to summarize with a number.
Time allocation
The Practice Track eligibility route itself references time in neuro-oncology: at least 25% of professional time in NO. How much of your week is actually devoted to neuro-oncology versus your general practice influences both your income mix and your eligibility.
Where Neuro-Oncology Physicians Work
The employer landscape also shapes how credentials matter. Verified facts from the eligibility criteria point to the settings where NO carries the most structural weight:
- UCNS-accredited neuro-oncology training programs. Faculty teaching NO fellows can qualify through the Academic Appointment route, and internationally trained faculty at these programs have a dedicated route in which passing the next available exam can be a condition of appointment.
- Comprehensive cancer centers and tertiary hospitals. These institutions concentrate multidisciplinary brain tumor teams where subspecialty credentials signal focused expertise.
- Academic departments of neurology, oncology, neurosurgery, and radiation oncology. A full-time academic appointment teaching NO can also satisfy a component of the Practice Track route.
Notice what this means for earnings analysis: in some academic settings, certification is tied to appointment conditions or program recruitment and retention, which is an indirect but concrete link between credential and employment. That is a different thing from a measurable salary premium. For more on the employment side, see our overview of NO jobs.
| Factor | How It Relates to NO | Earnings Effect |
|---|---|---|
| Primary board certification | Required prerequisite | Largest determinant; independent of NO |
| Practice setting | Academic and accredited-program roles link to eligibility routes | Varies by employer compensation model |
| Time in neuro-oncology | 25% threshold for Practice Track | Shapes clinical mix and income structure |
| NO credential itself | Subspecialty recognition; sometimes an appointment condition | No verified premium attributable to it alone |
The Cost Side of the Equation
If the benefit side of the ledger is hard to quantify, the cost side is at least partly documented, though it comes with a genuine source conflict that candidates should understand rather than gloss over.
Initial certification fees: two published numbers
The current general UCNS certification fee schedule and FAQ publish a total of $1,700, made up of a $680 nonrefundable application fee plus a $1,020 examination fee. They list no member versus non-member price tiers. However, the undated store page for the exact NO product (EX_NO_I) displays $2,200. The official pages do not explicitly reconcile these figures.
The fellowship discount
Eligible graduates of UCNS-accredited fellowships receive a $250 discount when they apply within 48 months of completion, provided the program was accredited at the time they finished. For a recent fellowship graduate, this is a straightforward reason not to delay the application.
Late fees
Missing the standard application deadline is expensive relative to the base fee. The extended deadline carries a $500 late fee. For a credential whose total fee is in the range of $1,700 to $2,200, a $500 penalty is a meaningful percentage, so mark the dates carefully.
The non-fee costs
Fees are the visible part. The real economics also include study time taken from clinical or research work, any review courses or books you buy, and the time away for the four-hour exam plus setup and a 15-minute break. Remote candidates must complete equipment and workspace checks and use the required Guardian browser, so allow extra appointment time beyond the four-hour examination. Test center candidates use Meazure Learning locations, an option that took effect January 1, 2025, superseding older remote-only instructions.
Key Takeaway
Because the credential cost is modest relative to physician compensation but the benefit is unmeasured, the honest framing is risk management and professional positioning, not a guaranteed pay bump. Budget conservatively using the higher fee figure until your invoice says otherwise.
Route Choice and Timeline: Why the 2027 Sitting Matters for Earnings Planning
A common mistake in salary planning is assuming you can sit for the exam whenever it suits your career timeline. The NO initial exam runs biennially in odd-numbered years. There is no 2026 sitting. The next published exam window is December 6-10, 2027. Applications open March 1, the standard deadline is June 1, and the extended deadline of June 15 carries the $500 late fee. Approved candidates schedule their appointment between July 19 and November 22. See our NO exam dates guide for the scheduling details.
For earnings planning, this biennial cycle matters. If you finish training or reach the practice-time threshold just after an application window closes, you may wait roughly two years for the next opportunity. If a job offer or promotion depends on certification, that delay has real financial consequences.
Four alternative routes, one required
Candidates complete one of four alternative routes, not all four. They are credentialing pathways, not additional exams:
- UCNS-Accredited Fellowship. At least 12 months of neuro-oncology fellowship, with application within 48 months of completion and director verification or a completion certificate. A fellow applying before completion must finish at least 25 days before exam week, with confirmation received within 20 days of completion.
- Practice Track. At least 36 months after residency with at least 25% of professional time in neuro-oncology within the prior 60 months, measured to the application deadline or August 31, whichever is later. Two physician letters together must cover the full interval. This route also requires one of: at least 12 months of formal non-accredited post-residency NO training, at least 50 AMA PRA Category 1 NO-specific CME hours in the prior 60 months, or a full-time academic appointment teaching NO with a chair letter.
- Academic Appointment at a UCNS-Accredited Training Program. A full-time faculty appointment teaching NO fellows, with chair verification and the practice-time and practice-pattern requirements.
- Internationally Trained Faculty at UCNS-Accredited Training Programs. An active program-director or faculty appointment (or written offer), chair verification that passing the next available exam is a condition of appointment, and documentation of the required practice period within the preceding 60 months. A World Directory of Medical Schools diploma and approved foreign primary certification are accepted, alongside valid licensure.
The practical earnings point: mid-career physicians who built a neuro-oncology practice without formal fellowship training are not shut out. The Practice Track exists for them. Read the full detail in our NO requirements guide.
Keeping the Credential: C-cert as an Ongoing Expense
Many earnings analyses stop at the exam. For NO, the ongoing cost of staying certified belongs in any honest accounting. Validity is maintained through annual Continuous Certification (C-cert), which begins the calendar year after initial certification. The older ten-year renewal model is not the current rule.
Requirements include:
- Maintaining the required primary board certification and unrestricted license
- Reading the annual list of up to ten articles or guidelines
- Paying the $175 annual fee per subspecialty ($150 if paid by June 1)
- Passing that year's C-cert quiz by December 31
The quiz is a separate activity: 25 questions, 100 minutes, open-article, unproctored, with an 80% passing requirement and up to three attempts. None of those quiz logistics describe the initial exam. No additional UCNS CME-hour reporting is required beyond C-cert, although your primary board's CME obligations remain separate, and completing the activity can earn CME. Two consecutive years of noncompliance lead to loss of certification.
Clinical Breadth the Exam Rewards
Salary conversations often ignore a quieter benefit: preparing for NO forces breadth. The exam tests four weighted content areas, and the content outline currently linked is the version revised October 10, 2018, not a newly issued 2026 blueprint. Candidates should read it directly alongside our guide to all four NO exam domains.
Domain 1: Adult Primary Nervous System Tumors (35%)
The largest domain. Coverage includes diagnostic methods (clinical history and examination, laboratory testing, imaging, neuropathology, other neurodiagnostic procedures) and standard, experimental, and medical neuro-oncologic therapies.
- Neuropathology-to-treatment reasoning is heavily rewarded
- Imaging interpretation sits alongside therapy selection
Domain 2: Pediatric Primary Nervous System Tumors (25%)
Same diagnostic and therapeutic structure as the adult domain, applied to pediatric populations. Neurologists and adult oncologists often need the most remediation here.
Domain 3: Metastatic Cancer to the Nervous System (15%)
Brain and spinal cord metastases, skull base disease, leptomeningeal disease, epidural disease, plexus and peripheral nerve involvement, and spinal cord compression.
Domain 4: Systemic Cancer-Related Neurologic Disorders (25%)
Toxic, nutritional, and metabolic encephalopathy; central and systemic infections; cerebrovascular disease; blood products and growth-factor support; paraneoplastic syndromes; adverse effects of surgery, drugs, and radiation; seizures; raised intracranial pressure; venous thrombosis; neutropenia, thrombocytopenia, and anemia; transplantation-related neurologic complications; pain and headache care; and palliation and end-of-life care.
- Note: the detailed section heading reads "Systemic," while the summary table prints "Systematic" in the outline itself; this is an internal wording discrepancy, not a different domain.
The point for career economics: a physician who masters this full scope, including palliation, thrombosis, and treatment-related complications, becomes more useful to a multidisciplinary brain tumor team. That usefulness is an indirect career asset, though it is not a quantified salary effect. If you are wondering how demanding this scope is, see how hard the NO exam really is, and for outcomes data see the NO pass rate analysis. Official statistics report an 85% historical average initial NO pass rate, but with no disclosed cohort range or denominator, and it is not a 2025 or 2026 figure.
A Domain-Weighted Prep Sequence
Since the next sitting is December 2027, you have time to sequence preparation rather than cram. The exam is 200 multiple-choice questions in four hours, closed-book, in two parts with a 15-minute structured break. You cannot return to a part after submitting it. A scored-versus-pretest split is not publicly specified, and no numerical passing score is verified, so aim for broad competence rather than gaming a threshold. Our passing score explainer covers what is and is not known.
Adult tumors first (35% of the exam)
- Neuropathology, imaging, and therapy selection for adult primary tumors
- Heaviest weight, so it gets the longest block
Pediatric tumors (25%)
- Pair with Block 1 so adult versus pediatric contrasts stay fresh
- Spend extra time here if your training was adult-focused
Systemic cancer-related disorders (25%)
- Encephalopathy, paraneoplastic syndromes, treatment complications, thrombosis, palliation
- Broad and fact-dense; revisit more than once
Metastatic disease (15%) plus mixed review
- Leptomeningeal, epidural, and spinal cord compression scenarios
- Finish with full-length timed practice split into two parts to rehearse the break structure
For a fuller framework, see our NO study guide, and when you are ready to test yourself against realistic questions, use the NO practice tests. For a compressed review near exam day, the NO cheat sheet condenses the must-know facts.
Frequently Asked Questions
No verified source isolates a salary premium attributable to NO alone. Compensation depends mainly on primary specialty, practice setting, region, and time allocation. In some academic settings the credential can be an appointment condition, which affects employment rather than pay directly.
UCNS's general fee schedule publishes $1,700 total ($680 application plus $1,020 exam), but the exact NO store page shows $2,200. The official pages do not reconcile this, so verify the amount on your application invoice. A $250 discount applies to eligible fellowship graduates applying within 48 months.
No. The initial exam runs in odd-numbered years, so there is no 2026 sitting. The next published exam window is December 6-10, 2027, with applications opening March 1 and a standard deadline of June 1.
Annual C-cert costs $175 per subspecialty, or $150 if paid by June 1, plus passing that year's quiz by December 31. Two consecutive years of noncompliance lead to loss of certification.
No. Fellowship is one of four alternative routes. The Practice Track allows physicians with at least 36 months of practice and 25% of professional time in neuro-oncology to qualify, subject to additional requirements. See the overview of NO for background on the credential.
Before committing, confirm every date, fee, and eligibility detail directly with UCNS, since these details change and this guide cannot substitute for your official application materials.